Diphenylether

Diphenylether

SCHEMBL148065

OCCOCCOCCO.c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.58
RECQL P46063 1/20 0.58
LTA4H P09960 8/20 0.55
TSHR P16473 2/20 0.55
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
NR1H2 P55055 1/20 0.48
BAX Q07812 1/20 0.48
MAPK1 P28482 1/20 0.46
PLA2G2A P14555 1/20 0.45
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
MAOA P21397 1/20 0.43
GAA P10253 1/20 0.42
GALR3 O60755 1/20 0.42
FFAR1 O14842 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetraethylene Glycol SCHEMBL2481799 1.00 ALDH1A1 (0.58) ALDH1A1RECQLLTA4HTSHRKMT2A
Diphenylether SCHEMBL514872 0.98 ALDH1A1 (0.60) ALDH1A1RECQLLTA4HTSHRKMT2A
Diphenylether SCHEMBL27574926 0.94 ALDH1A1 (0.52) ALDH1A1RECQLLTA4HTSHRKMT2A
Diphenylether SCHEMBL15348001 0.91 ALDH1A1 (0.54) ALDH1A1RECQLLTA4HTSHRKMT2A
SCHEMBL10437660 0.90 ALDH1A1 (0.64) ALDH1A1RECQLLTA4HKMT2AMEN1
Diphenylether SCHEMBL19064985 0.90 ALDH1A1 (0.48) ALDH1A1RECQLLTA4HTSHRGAA
Diphenylether SCHEMBL28826764 0.90 ALDH1A1 (0.48) ALDH1A1RECQLLTA4HTSHRKMT2A
Diphenylether SCHEMBL11438863 0.88 LTA4H (0.52) ALDH1A1RECQLLTA4HTSHRNR1H2
Diphenylether SCHEMBL27753676 0.87 LTA4H (0.62) ALDH1A1RECQLLTA4HTSHRKMT2A
Diphenylether SCHEMBL7865304 0.85 LMNA (0.47) ALDH1A1RECQLLTA4HTSHRNR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250198980-A1 COMBINATORIAL HIGH-THROUGHPUT SCREENING OF COMPLEX POLYMERIC ENZYME IMMOBILIZATION SUPPORTS THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2025-06-19 US claimed
US-20240207795-A1 SOLVENT COMPOSITION DOW GLOBAL TECHNOLOGIES LLC (US) 2024-06-27 US claimed
EP-4334135-A1 SOLVENT COMPOSITION Dow Global Technologies LLC (US) 2024-03-13 EP claimed
CN-117157198-A Solvent composition 陶氏环球技术有限责任公司 2023-12-01 CN claimed
WO-2022235343-A1 SOLVENT COMPOSITION DOW GLOBAL TECHNOLOGIES LLC (US) 2022-11-10 WO claimed
EP-2692807-B1 AQUEOUS COATING COMPOSITION DAINIPPON TORYO KK (JP) 2019-05-08 EP claimed
EP-2935441-B1 LOW EMISSION EPOXY CURING AGENTS BLUE CUBE IP LLC (US) 2017-02-01 EP claimed
US-9469721-B2 Low emission epoxy curing agents BLUE CUBE IP LLC (US) 2016-10-18 US claimed
US-20150315378-A1 LOW EMISSION EPOXY CURING AGENTS BLUE CUBE IP LLC 2015-11-05 US claimed
EP-2935441-A1 LOW EMISSION EPOXY CURING AGENTS Dow Global Technologies LLC (US) 2015-10-28 EP claimed
WO-2014099542-A1 LOW EMISSION EPOXY CURING AGENTS DOW GLOBAL TECHNOLOGIES LLC (US) 2014-06-26 WO claimed
US-5326590-A Method of rejuvenating rubber printing blankets CLAYTON CHEMICAL COMPANY (US) 1994-07-05 US claimed
US-12404363-B2 Epoxy resin composition and cured product of same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-09-02 US disclosed
US-20250198980-A1 COMBINATORIAL HIGH-THROUGHPUT SCREENING OF COMPLEX POLYMERIC ENZYME IMMOBILIZATION SUPPORTS THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2025-06-19 US disclosed
US-20250171581-A1 EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-05-29 US disclosed
EP-4516834-A1 EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-03-05 EP disclosed
US-6380435-B2 CHEMICAL INTERMEDIATE FOR POLYMERIZATION CATALYST NIPPON SHOKUBAI CO., LTD. (JP) 2002-04-30 US disclosed
US-20010014739-A1 Purifying process of tetrakis (fluoroaryl) borate.magnesium halide, tetrakis (fluoroaryl) borate.ether complex and producing process of the same, and producing process of tetrakis (fluoroaryl) borate derivative NIPPON SHOKUBAI CO., LTD. 2001-08-16 US disclosed
US-6215025-B1 Method for purifying tetrakis (fluoroaryl) borate/magnesium halide, tetrakis (fluoroaryl) borate/ether complex and process for preparing the same, and process for preparing tetrakis (fluoroaryl) borate derivative NIPPON SHOKUBAI CO., LTD. (JP) 2001-04-10 US disclosed
EP-0913400-A1 METHOD FOR PURIFYING TETRAKIS(FLUOROARYL) BORATE/MAGNESIUM HALIDE, TETRAKIS(FLUOROARYL) BORATE/ETHER COMPLEX AND PROCESS FOR PREPARING THE SAME, AND PROCESS FOR PREPARING TETRAKIS(FLUOROARYL) BORATE DERIVATIVE Nippon Shokubai Co., Ltd. (JP) 1999-05-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010014739-A1 Purifying process of tetrakis (fluoroaryl) borate.magnesium halide, tetrakis (fluoroaryl) borate.ether complex and producing process of the same, and producing process of tetrakis (fluoroaryl) borate derivative BMX, BRIX1, CYP4X1 ALDH1A1 3378/4885RECQL 1292/4885LTA4H 2227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.